Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Medtronic Bounces Back During Quarter Four Of Financial Year 2021 As Procedure Volumes Normalize

Jun 03 2021

• By Barnaby Pickering

Earning Report Q4

Related Content

12 Deaths Prompt Another Class I Recall For Medtronic’s HeartWare – The Firm’s Fourth In Recent Weeks

Apr 15 2021

Medtronic Remains Aggressive In Diabetes Market, Obtains Two CE Marks

May 28 2021

Medtronic Pulls HeartWare Devices After Higher Risk Of Death Compared To Abbott’s HeartMate 3

Jun 03 2021

Market Intel: Rivalry Among Insulin Pump Makers Heats Up With Expected Launches In 2021

Feb 16 2021

Medtronic, Farapulse Advance Pulsed Field Ablation With US Trials

Mar 11 2021

Q&A: Medtronic CEO Discusses Challenges Of Taking Helm During COVID-19, Exciting Innovations, More

Mar 09 2021

Long-Term Data Confirm Durability Of Medtronic’s DTM Back Pain Therapy

Oct 21 2020

Medtronic Sales Slump In Q4 2020 But CEO Reveals Appetite For Tuck-In Acquisitions

May 22 2020

Related Companies

Medtronic plc

Additional Topics

Sales & Earnings Commercial Companies Business Strategies Cardiology Diabetic Care Cardiovascular Medical Device

More from Cardiology

More from Device Area

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window